Phathom Pharmaceuticals (PHAT) EBIT (2018 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly EBIT came in at -$15.5 million in Q1 2026, up 80.37% year-on-year from -$8.6 million in Q1 2025, and down 161.08% on a QoQ basis from -$5.9 million in Q4 2025.
Phathom Pharmaceuticals (PHAT) EBIT (2018 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 9 years of EBIT data on file, last reported at -$15.5 million in Q1 2026.
- On a quarterly basis, EBIT rose 80.37% year-over-year to -$15.5 million in Q1 2026; TTM through Mar 2026 was -$96.6 million, a 66.27% increase from a year earlier, with the FY2025 full-year figure at -$160.0 million, up 42.34% from the prior year.
- EBIT for Q1 2026 stood at -$15.5 million, down from -$5.9 million in the prior quarter.
- Over the last five years, EBIT for PHAT reached as high as -$5.9 million in Q4 2025 and fell as low as -$78.9 million in Q1 2025.
- Historically, EBIT has averaged -$46.6 million across 5 years, with a median of -$45.4 million in 2022.
- Across the five-year window, EBIT tumbled 143.84% in 2024 and soared 90.02% in 2025, its largest moves.
- Year by year, EBIT stood at -$46.6 million in 2022, then sank by 49.81% to -$69.9 million in 2023, then advanced by 14.97% to -$59.4 million in 2024, then surged by 90.02% to -$5.9 million in 2025, then tumbled by 161.08% to -$15.5 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$15.5 million in Q1 2026, -$5.9 million in Q4 2025, and -$15.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Phathom Pharmaceuticals | 945.22 Mn | 761.46 Mn | 46.31 Mn | -15.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.48 Mn |
| Dec 31, 2025 | -5.93 Mn |
| Sep 30, 2025 | -15.27 Mn |
| Jun 30, 2025 | -59.92 Mn |
| Mar 31, 2025 | -78.86 Mn |
| Dec 31, 2024 | -59.42 Mn |
| Sep 30, 2024 | -70.80 Mn |
| Jun 30, 2024 | -77.30 Mn |
| Mar 31, 2024 | -69.95 Mn |
| Dec 31, 2023 | -69.88 Mn |
| Sep 30, 2023 | -35.66 Mn |
| Jun 30, 2023 | -31.70 Mn |
| Mar 31, 2023 | -30.08 Mn |
| Dec 31, 2022 | -46.64 Mn |
| Sep 30, 2022 | -42.53 Mn |
| Jun 30, 2022 | -45.36 Mn |
| Mar 31, 2022 | -37.91 Mn |
| Dec 31, 2021 | -33.04 Mn |
| Sep 30, 2021 | -33.14 Mn |
| Jun 30, 2021 | -35.32 Mn |